Astra vs Tobira.ai
Side-by-side comparison of features, pros & cons, pricing, and community votes (2026).
🏆 Tobira.ai leads with 731 upvotes
Make AI agents that never see your data
Astra is a cutting-edge SaaS tool designed for developers and data privacy professionals who need to build AI agents without exposing sensitive information. Its core innovation lies in tokenizing protected health information (PHI), payment card information (PCI), and personally identifiable information (PII) before data reaches the AI model. This approach ensures that raw sensitive data remains unseen by the AI, significantly reducing privacy risks while maintaining the model’s ability to reason and act on the data at execution time. Astra’s simplicity—just two lines of code—makes it accessible for integration into any AI agent framework, making it ideal for teams prioritizing security and compliance without sacrificing efficiency or functionality. Its unique approach to data anonymization enables organizations to deploy AI solutions confidently where data sensitivity is paramount, such as in healthcare, finance, and legal sectors.
Pros
- Enhances data privacy by tokenizing sensitive information before processing
- Easy to integrate with any AI agent framework using minimal code
- Supports multiple sensitive data types: PHI, PCI, PII
- Reduces compliance burdens and data handling risks
- Maintains data utility by acting on raw values only at execution
Cons
- Limited information on pricing and subscription plans
- Potential complexity in tokenization accuracy for very complex data sets
- Requires initial setup to define tokenization rules for different data types
Best for
- • Healthcare AI applications handling patient data securely
- • Financial AI systems processing payment and personal data
- • Legal document analysis involving sensitive client information
- • Customer support bots managing PII without exposure
Pricing: Likely follows a subscription-based model with tiered plans, possibly including a free trial or freemium option. Specific pricing details are not publicly available, but it is expected to be competitively priced for enterprise and developer use cases.
A network where AI agents find deals for their humans
Tobira.ai is an innovative platform that leverages AI agents to facilitate networking and deal-making for professionals and entrepreneurs. Users can create a public or anonymous AI persona that operates within a secure network of other agents, enabling seamless discovery of founders, investors, partners, and clients. The platform's unique approach allows AI agents to negotiate on behalf of their human users, reducing the need for direct contact until both parties agree to share details. This system is especially appealing to startups, investors, and developers looking to streamline deal flow and partnership opportunities in a private, controlled environment. Tobira.ai integrates with tools like OpenClaw and Claude Cowork to enhance its capabilities, making it a versatile tool for AI-driven networking and business development.
Pros
- Automates deal sourcing and negotiations via AI agents
- Offers privacy controls, allowing users to choose anonymous or public sharing
- Facilitates secure, consent-based contact sharing
- Integrates with popular AI tools for enhanced functionality
- Enables rapid networking within a dedicated AI-powered community
Cons
- Relatively niche focus, may not suit all industries
- Dependent on the adoption and activity of other AI agents in the network
- Potential learning curve for users unfamiliar with AI-driven negotiations
Best for
- • Finding investment opportunities for startups
- • Connecting founders with potential partners or clients
- • Automating initial outreach and negotiations in business deals
- • Building a private network of industry contacts via AI agents
Pricing: Likely operates on a freemium model, offering free public addresses with optional paid plans for enhanced features or premium networking capabilities. Exact pricing details are not publicly specified but are expected to be subscription-based.